Abstract
The present industry update covers the period 1-28 February 2017. Information was sourced primarily from company press releases, regulatory and patent agencies, scientific literature and various news websites. A report issued this month indicated that the recent American election has influenced the rate and volume of pharma acquisitions and mergers (A&M) in the final quarter of 2016 and it remains to be seen what (if any) is the effect on the therapeutic drug delivery sector in the longer term. There was positive approval news this month for Valeant, Intellipharmaceutics and Pfizer for products that offered novel therapeutic delivery. Several companies including Trutag and Novasep announced significant investment in new manufacturing facilities and strategic alliances this month.
| Original language | English |
|---|---|
| Pages (from-to) | 367-372 |
| Number of pages | 6 |
| Journal | Therapeutic Delivery |
| Volume | 8 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 2017 |
| Externally published | Yes |
Keywords
- blood-brain barrier
- combination products
- nanotechnology